Long-term outcome of diffuse large B-cell lymphoma: Impact of biosimilar rituximab and radiation
Long-term outcome of diffuse large B-cell lymphoma: Impact of biosimilar rituximab and radiation
About this item
Full title
Author / Creator
Ganesan, P , Sagar, T , Kannan, K , Radhakrishnan, V , Rajaraman, S , John, A , Sundersingh, S , Mahajan, V and Ganesan, T
Publisher
Mumbai: Wolters Kluwer India Pvt. Ltd
Journal title
Language
English
Formats
Publication information
Publisher
Mumbai: Wolters Kluwer India Pvt. Ltd
Subjects
More information
Scope and Contents
Contents
INTRODUCTION: Rituximab (R)-CHOP improves survival over CHOP in diffuse large B-cell lymphoma (DLBCL). The availability of biosimilar rituximab in India has increased access of this drug. We report on the impact of treatment on outcomes with special emphasis on the impact of biosimilar rituximab and radiation. METHODS: Outcomes of adults (age 15-60...
Alternative Titles
Full title
Long-term outcome of diffuse large B-cell lymphoma: Impact of biosimilar rituximab and radiation
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_2007030323
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2007030323
Other Identifiers
ISSN
0019-509X
E-ISSN
1998-4774
DOI
10.4103/ijc.IJC_241_17
